Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;23(2):148-150.
doi: 10.1016/S1473-3099(22)00833-7. Epub 2023 Jan 5.

Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months

João Malato  1 , Ruy M Ribeiro  2 , Eugénia Fernandes  3 , Pedro Pinto Leite  3 , Pedro Casaca  3 , Carlos Antunes  4 , Válter R Fonseca  5 , Manuel Carmo Gomes  6 , Luis Graca  7
Affiliations

Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months

João Malato et al. Lancet Infect Dis. 2023 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Stability of hybrid immunity protection against BA.5 infection following infection with BA.1 or BA.2 subvariants (A) Incidence of documented SARS-CoV-2 infection overlaid with the period of dominance of the BA.1 and BA.2 variants, Jan 1–Apr 14, 2022, divided into 15-day sub-intervals (shades of blue), and the period of dominance of the BA.5 variant, Jun 1–Sep 14, 2022, also divided into 15-day sub-intervals (shades of purple). Two illustrative comparisons are represented. In period d (BA.5 dominance), the risk of infection was compared between individuals with a first documented infection in one of the seven subintervals of BA.1 and BA.2 dominance (A–G), represented with the solid arrow. In the second example with the dashed arrow, in period a of BA.5 dominance, the risk of infection was compared between individuals with a first documented infection in the first four periods of BA.1 and BA.2 dominance (A–D), as reinfections were only considered 90 days following the first infection. (B) RR of reinfection versus first infection in each subinterval of the period of BA.5 dominance (curves a–g, corresponding with the periods of the same letter as in (A) over time since the first infection. The increase in risk is well described by a saturating function (appendix pp 5, 9) as represented by the fitted line (dashed, black). RR=relative risk.
See this image and copyright information in PMC

References

    1. Malato J, Ribeiro RM, Leite PP, et al. Risk of BA.5 Infection among persons exposed to previous SARS-CoV-2 Variants. N Engl J Med. 2022;387:953–954. - PMC - PubMed
    1. Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Protective effect of previous SARS-CoV-2 infection against omicron BA.4 and BA.5 subvariants. N Engl J Med. 2022;387:1620–1622. - PMC - PubMed
    1. Hansen CH, Friis NU, Bager P, et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00595-3. published online Oct 18. - DOI - PMC - PubMed
    1. Chemaitelly H, Tang P, Hasan MR, et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med. 2021;385:e83. - PMC - PubMed
    1. Goldberg Y, Mandel M, Bar-On YM, et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N Engl J Med. 2022;386:2201–2212. - PMC - PubMed

Publication types